These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 17449063
1. Intravenous immunoglobulin in MS: promise or failure? Fazekas F, Strasser-Fuchs S, Hommes OR. J Neurol Sci; 2007 Aug 15; 259(1-2):61-6. PubMed ID: 17449063 [Abstract] [Full Text] [Related]
2. Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trials. Sørensen PS. Neurol Sci; 2003 Oct 15; 24 Suppl 4():S227-30. PubMed ID: 14598048 [Abstract] [Full Text] [Related]
3. Intravenous polyclonal human immunoglobulins in multiple sclerosis. Soelberg Sorensen P. Neurodegener Dis; 2008 Oct 15; 5(1):8-15. PubMed ID: 18075269 [Abstract] [Full Text] [Related]
4. Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis. Humle Jorgensen S, Sorensen PS. J Neurol Sci; 2005 Jun 15; 233(1-2):61-5. PubMed ID: 15949496 [Abstract] [Full Text] [Related]
12. The Austrian Immunoglobulin in MS (AIMS) study: final analysis. Strasser-Fuchs S, Fazekas F, Deisenhammer F, Nahler G, Mamoli B. Mult Scler; 2000 Oct 22; 6 Suppl 2():S9-13. PubMed ID: 11188778 [Abstract] [Full Text] [Related]
13. Intravenous immune globulin in multiple sclerosis: clinical and neuroradiological results and implications for possible mechanisms of action. Achiron A, Barak Y, Goren M, Gabbay U, Miron S, Rotstein Z, Noy S, Sarova-Pinhas I. Clin Exp Immunol; 1996 May 22; 104 Suppl 1():67-70. PubMed ID: 8625547 [Abstract] [Full Text] [Related]
17. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders. Gürcan HM, Ahmed AR. Ann Pharmacother; 2007 May 22; 41(5):812-23. PubMed ID: 17440006 [Abstract] [Full Text] [Related]
18. [Intravenous immunoglobulins for relapsing-remitting multiple sclerosis after failure of treatment with other immuno-modulators]. Lebrun C, Ghetau G, Bourg V, Chanalet S, Dumas S, Chatel M. Rev Neurol (Paris); 2003 Jul 22; 159(6-7 Pt 1):648-51. PubMed ID: 12910072 [Abstract] [Full Text] [Related]
19. High dose IVIG in the post partum period for prevention of exacerbations in MS. Haas J. Mult Scler; 2000 Oct 22; 6 Suppl 2():S18-20; discussion S33. PubMed ID: 11188773 [Abstract] [Full Text] [Related]
20. How effective is intravenous immunoglobulin for the treatment of relapsing-remitting multiple sclerosis? Cohen JA. Nat Clin Pract Neurol; 2008 Nov 22; 4(11):588-9. PubMed ID: 18852726 [Abstract] [Full Text] [Related] Page: [Next] [New Search]